ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels

Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

By Sneha S K June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to ...
Medical Device and Diagnostic Industry (MD+DI)Opinion

Dexcom Learns a Lesson in Transparency

Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
TMCnet

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

Through independent moderation by Vital Findings, council members reinforced that Dexcom remains a life-changing, essential ...

Dexcom study finds G7 glucose monitor improves blood sugar control in type 2 diabetes patients

A new study presented at the American Diabetes Association found that Dexcom’s G7 continuous glucose monitor significantly ...
The Motley Fool

Reason to sell: diabetes therapies in development

DexCom develops continuous glucose monitoring (CGM) systems to help people with diabetes track their blood glucose levels. This technology improves patients' health outcomes. That's why DexCom has ...
Yahoo Finance

DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...